Skip to main content

Balchem Corporation Value Stock - Dividend - Research Selection

Balchem corporation

ISIN: US0576652004 , WKN: 905650

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Balchem Corp (NASDAQ:BCPC) Passes Caviar Cruise Quality Screen with 33% ROIC and Minimal Debt

2026-06-03
Discover how Balchem Corp (BCPC) meets strict quality investing criteria with 33% ROIC, strong cash flow, and durable competitive advantages for long-term portfolio growth.

My Top Dividend Growth Picks In Each GICS Sector

2026-05-19
I present my top dividend growth picks for each of the 11 GICS sectors, emphasizing discounted valuations and safe, growing dividends.

MSM for Knee Health Study: Clinical Research Supporting Knee Comfort and Quality of Life with OptiMSM®

2026-05-08
Clinical research shows MSM knee health featuring OptiMSM® supports knee quality of life, improves perceived knee comfort, and enhances overall health perceptions in adults with mild knee...

HC Wainwright & Co. Maintains Buy on Balchem, Raises Price Target to $5.16

2026-05-04
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and raises the price target from $5.1 to $5.16.

Balchem : Announces Global Price Increase for Animal Nutrition and Health Products

2026-05-01
FOR IMMEDIATE RELEASE Balchem Corporation Announces Global Price Increase for Animal Nutrition & Health Products Montvale, New Jersey, May 1, 202C. Balchem...

Balchem Q1 2026 Earnings Call Transcript

2026-04-30

Balchem Corporation (BCPC) Q1 2026 Earnings Call Transcript

2026-04-30
Balchem Corporation (BCPC) Q1 2026 Earnings Call April 30, 2026 11:00 AM EDTCompany ParticipantsCarl Bengtsson - Executive VP, CFO, Treasurer and GM of...

Transcript : Balchem Corporation, Q1 2026 Earnings Call, Apr 30, 2026

2026-04-30
Presentation Operator MessageOperator Thank you for standing by, and welcome to the Balchem's First Quarter 2026 Earnings Conference Call. [Operator Instructions] I'd now like to turn the call

Balchem Corp (NASDAQ:BCPC) Posts Record First Quarter, Beating Estimates Amid Tariff Uncertainty

2026-04-30
Balchem reports record Q1 revenue of $270.7M and adjusted EPS of $1.33, beating estimates amid trade uncertainty.

Balchem Corporation 2026 Q1 - Results - Earnings Call Presentation

2026-04-30
2026-04-30. The following slide deck was published by Balchem Corporation in conjunction with their 2026 Q1 earnings call.